Innate immune activation after transfusion of stored red blood cells

Transfusion Medicine Reviews

Volumn 27, Issue 2, 2013, Pages 113-118

  Neal, Matthew D ^a   Raval, Jay S ^b   Triulzi, Darrell J ^c,d   Simmons, Richard L ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d INSTITUTE FOR TRANSFUSION MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEME; HEMIN; HEMOGLOBIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 8; MYELOID DIFFERENTIATION FACTOR 88; PROTEIN KINASE C; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; TOLL LIKE RECEPTOR 4;

ADVERSE OUTCOME; COMPLEMENT ACTIVATION; COMPLEMENT CLASSICAL PATHWAY; CYTOKINE RELEASE; ENDOTOXEMIA; ERYTHROCYTE PRESERVATION; ERYTHROCYTE TRANSFUSION; HEMOLYSIS; HOMEOSTASIS; HUMAN; INNATE IMMUNITY; LEUKOCYTE ADHERENCE; MEMBRANE MICROPARTICLE; NEUTROPHIL; REPERFUSION INJURY; REVIEW; TRANSFUSION RELATED ACUTE LUNG INJURY;

BLOOD PRESERVATION; ERYTHROCYTE TRANSFUSION; ERYTHROCYTES; HEMOLYSIS; HUMANS; IMMUNITY, INNATE; NEUTROPHIL ACTIVATION; REACTIVE OXYGEN SPECIES; TRANSPLANTATION IMMUNOLOGY;

EID: 84876147708     PISSN: 08877963     EISSN: 15329496     Source Type: Journal    
DOI: 10.1016/j.tmrv.2013.01.001     Document Type: Review

References (60)

1. Vamvakas E.C., Carven J.H. Transfusion and postoperative pneumonia in coronary artery bypass graft surgery: effect of the length of storage of transfused red cells. Transfusion 1999, 39:701-710.
2. Zallen G., Offner P.J., Moore E.E., Blackwell J., Ciesla D.J., Gabriel J., et al. Age of transfused blood is an independent risk factor for postinjury multiple organ failure. Am J Surg 1999, 178:570-572.
3. Koch C.G., Li L., Sessler D.I., Figueroa P., Hoeltge G.A., Mihaljevic T., et al. Duration of red-cell storage and complications after cardiac surgery. N Engl J Med 2008, 358:1229-1239.
4. Donadee C., Raat N.J., Kanias T., Tejero J., Lee J.S., Kelley E.E., et al. Nitric oxide scavenging by red blood cell microparticles and cell-free hemoglobin as a mechanism for the red cell storage lesion. Circulation 2011, 124:465-476.
5. Dumont L.J., AuBuchon J.P. Evaluation of proposed FDA criteria for the evaluation of radiolabeled red cell recovery trials. Transfusion 2008, 48:1053-1060.
6. Luten M., Roerdinkholder-Stoelwinder B., Schaap N.P., de Grip W.J., Bos H.J., Bosman G.J. Survival of red blood cells after transfusion: a comparison between red cells concentrates of different storage periods. Transfusion 2008, 48:1478-1485.
7. Rother R.P., Bell L., Hillmen P., Gladwin M.T. The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease. JAMA 2005, 293:1653-1662.
8. Winslow R.M. Red cell substitutes. Semin Hematol 2007, 44:51-59.
9. Kluger R. Red cell substitutes from hemoglobin-do we start all over again?. Curr Opin Chem Biol 2010, 14:538-543.
10. Qian Q., Nath K.A., Wu Y., Daoud T.M., Sethi S. Hemolysis and acute kidney failure. Am J Kidney Dis 2010, 56:780-784.
11. Reiter C.D., Wang X., Tanus-Santos J.E., Hogg N., Cannon R.O., Schechter A.N., et al. Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease. Nat Med 2002, 8:1383-1389.
12. Nantakomol D., Dondorp A.M., Krudsood S., Udomsangpetch R., Pattanapanyasat K., Combes V., et al. Circulating red cell-derived microparticles in human malaria. J Infect Dis 2011, 203:700-706.
13. Wicher K.B., Fries E. Evolutionary aspects of hemoglobin scavengers. Antioxid Redox Signal 2010, 12:249-259.
14. Zuckerbraun B.S., Billiar T.R., Otterbein S.L., Kim P.K., Liu F., Choi A.M., et al. Carbon monoxide protects against liver failure through nitric oxide-induced heme oxygenase 1. J Exp Med 2003, 198:1707-1716.
15. Figueiredo R.T., Fernandez P.L., Mourao-Sa D.S., Porto B.N., Dutra F.F., Alves L.S., et al. Characterization of heme as activator of Toll-like receptor 4. J Biol Chem 2007, 282:20221-20229.
16. Hao K., Hanawa H., Ding L., Ota Y., Yoshida K., Toba K., et al. Free heme is a danger signal inducing expression of proinflammatory proteins in cultured cells derived from normal rat hearts. Mol Immunol 2011, 48:1191-1202.
17. Cosgrove S., Chotirmall S.H., Greene C.M., McElvaney N.G. Pulmonary proteases in the cystic fibrosis lung induce interleukin 8 expression from bronchial epithelial cells via a heme/meprin/epidermal growth factor receptor/Toll-like receptor pathway. J Biol Chem 2011, 286:7692-7704.
18. Piazza M., Damore G., Costa B., Gioannini T.L., Weiss J.P., Peri F. Hemin and a metabolic derivative coprohemin modulate the TLR4 pathway differently through different molecular targets. Innate Immun 2011, 17:293-301.
19. Lin T., Kwak Y.H., Sammy F., He P., Thundivalappil S., Sun G., et al. Synergistic inflammation is induced by blood degradation products with microbial Toll-like receptor agonists and is blocked by hemopexin. J Infect Dis 2010, 202:624-632.
20. Yang H., Wang H., Bernik T.R., Ivanova S., Wang H., Ulloa L., et al. Globin attenuates the innate immune response to endotoxin. Shock 2002, 17:485-490.
21. Larsen R., Gozzelino R., Jeney V., Tokaji L., Bozza F.A., Japiassu A.M., et al. A central role for free heme in the pathogenesis of severe sepsis. Sci Transl Med 2010, 2. 51ra71.
22. Su D., Roth R.I., Yoshida M., Levin J. Hemoglobin increases mortality from bacterial endotoxin. Infect Immun 1997, 65:1258-1266.
23. Poss K.D., Tonegawa S. Heme oxygenase 1 is required for mammalian iron reutilization. Proc Natl Acad Sci USA 1997, 94:10919-10924.
24. Hebert P.C., Wells G., Blajchman M.A., Marshall J., Martin C., Pagliarello G., et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. New Engl J Med 1999, 340:409-417.
25. Gunst M.A., Minei J.P. Transfusion of blood products and nosocomial infection in surgical patients. Curr Opin Crit Care 2007, 13:428-432.
26. Graca-Souza A.V., Arruda M.A., de Freitas M.S., Barja-Fidalgo C., Oliveira P.L. Neutrophil activation by heme: implications for inflammatory processes. Blood 2002, 99:4160-4165.
27. Porto B.N., Alves L.S., Fernandez P.L., Dutra T.P., Figueiredo R.T., Graca-Souza A.V., et al. Heme induces neutrophil migration and reactive oxygen species generation through signaling pathways characteristic of chemotactic receptors. J Biol Chem 2007, 282:24430-24436.
28. Monteiro A.P., Pinheiro C.S., Luna-Gomes T., Alves L.R., Maya-Monteiro C.M., Porto B.N., et al. Leukotriene B4 mediates neutrophil migration induced by heme. J Immunol 2011, 186:6562-6567.
29. Arruda M.A., Rossi A.G., de Freitas M.S., Barja-Fidalgo C., Graca-Souza A.V. Heme inhibits human neutrophil apoptosis: involvement of phosphoinositide 3-kinase MAPK, and NF-kappaB. J Immunol 2004, 173:2023-2030.
30. Roumenina L.T., Radanova M., Atanasov B.P., Popov K.T., Kaveri S.V., Lacroix-Desmazes S., et al. Heme interacts with c1q and inhibits the classical complement pathway. J Biol Chem 2011, 286:16459-16469.
31. Hayashi S., Takamiya R., Yamaguchi T., Matsumoto K., Tojo S.J., Tamatani T., et al. Induction of heme oxygenase-1 suppresses venular leukocyte adhesion elicited by oxidative stress: role of bilirubin generated by the enzyme. Circ Res 1999, 85:663-671.
32. Lotze M.T., Deisseroth A., Rubartelli A. Damage associated molecular pattern molecules. Clin Immunol 2007, 124:1-4.
33. Condliffe A.M., Kitchen E., Chilvers E.R. Neutrophil priming: pathophysiological consequences and underlying mechanisms. Clin Sci (Lond) 1998, 94:461-471.
34. Jank H., Salzer U. Vesicles generated during storage of red blood cells enhance the generation of radical oxygen species in activated neutrophils. Scientific World Journal 2011, 11:173-185.
35. Triulzi D.J. Transfusion-related acute lung injury: current concepts for the clinician. Anesth Analg 2009, 108:770-776.
36. Silliman C.C., Thurman G.W., Ambruso D.R. Stored blood components contain agents that prime the neutrophil NADPH oxidase through the platelet-activating-factor receptor. Vox Sang 1992, 63:133-136.
37. Silliman C.C., Clay K.L., Thurman G.W., Johnson C.A., Ambruso D.R. Partial characterization of lipids that develop during the routine storage of blood and prime the neutrophil NADPH oxidase. J Lab Clin Med 1994, 124:684-694.
38. Silliman C.C., Elzi D.J., Ambruso D.R., Musters R.J., Hamiel C., Harbeck R.J., et al. Lysophosphatidylcholines prime the NADPH oxidase and stimulate multiple neutrophil functions through changes in cytosolic calcium. J Leukoc Biol 2003, 73:511-524.
39. Silliman C.C., Voelkel N.F., Allard J.D., Elzi D.J., Tuder R.M., Johnson J.L., et al. Plasma and lipids from stored packed red blood cells cause acute lung injury in an animal model. J Clin Invest 1998, 101:1458-1467.
40. Weisbach V., Wanke C., Zingsem J., Zimmermann R., Eckstein R. Cytokine generation in whole blood, leukocyte-depleted and temporarily warmed red blood cell concentrates. Vox Sang 1999, 76:100-106.
41. Sachs U.J. Pathophysiology of TRALI: current concepts. Intensive Care Med 2007, 33(Suppl 1):S3-S11.
42. Khan S.Y., Kelher M.R., Heal J.M., Blumberg N., Boshkov L.K., Phipps R., et al. Soluble CD40 ligand accumulates in stored blood components, primes neutrophils through CD40, and is a potential cofactor in the development of transfusion-related acute lung injury. Blood 2006, 108:2455-2462.
43. Silliman C.C., Boshkov L.K., Mehdizadehkashi Z., Elzi D.J., Dickey W.O., Podlosky L., et al. Transfusion-related acute lung injury: epidemiology and a prospective analysis of etiologic factors. Blood 2003, 101:454-462.
44. Dumaswala U.J., Zhuo L., Jacobsen D.W., Jain S.K., Sukalski K.A. Protein and lipid oxidation of banked human erythrocytes: role of glutathione. Free Radic Biol Med 1999, 27:1041-1049.
45. Dumaswala U.J., Wilson M.J., Wu Y.L., Wykle J., Zhuo L., Douglass L.M., et al. Glutathione loading prevents free radical injury in red blood cells after storage. Free Radic Res 2000, 33:517-529.
46. IUPAC Compendium of Chemical Terminology, 2nd ed. (the "Gold Book") Accessed: October 15, 2012. http://goldbook.iupac.org/index.html.
47. Kim Y.M., Chung H.T., Simmons R.L., Billiar T.R. Cellular non-heme iron content is a determinant of nitric oxide-mediated apoptosis, necrosis, and caspase inhibition. J Biol Chem 2000, 275:10954-10961.
48. Kay M.M., Flowers N., Goodman J., Bosman G. Alteration in membrane protein band 3 associated with accelerated erythrocyte aging. Proc Natl Acad Sci USA 1989, 86:5834-5838.
49. Wautier J.L., Wautier M.P., Schmidt A.M., Anderson G.M., Hori O., Zoukourian C., et al. Advanced glycation end products (AGEs) on the surface of diabetic erythrocytes bind to the vessel wall via a specific receptor inducing oxidant stress in the vasculature: a link between surface-associated AGEs and diabetic complications. Proc Natl Acad Sci USA 1994, 91:7742-7746.
50. T. Kislinger, C. Fu, B. Huber, W. Qu, A. Taguchi, S. Du Yan, et al. N(epsilon)-(carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression, J Biol Chem; 274:31740-9.
51. Mangalmurti N.S., Chatterjee S., Cheng G., Andersen E., Mohammed A., Siegel D.L., et al. Advanced glycation end products on stored red blood cells increase endothelial reactive oxygen species generation through interaction with receptor for advanced glycation end products. Transfusion 2010, 50:2353-2361.
52. Lotze M.T., Tracey K.J. High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat Rev Immunol 2005, 5:331-342.
53. Steiner M.E., Assmann S.F., Levy J.H., Marshall J., Pulkrabek S., Sloan S.R., et al. Addressing the question of the effect of RBC storage on clinical outcomes: the Red Cell Storage Duration Study (RECESS) (Section 7). Transfus Apher Sci 2010, 43:107-116.
54. Lacroix J., Hebert P., Fergusson D., Tinmouth A., Blajchman M.A., Callum J., et al. The Age of Blood Evaluation (ABLE) randomized controlled trial: study design. Transfus Med Rev 2011, 25:197-205.
55. Fergusson D., Hutton B., Hogan D.L., LeBel L., Blajchman M.A., Ford J.C., et al. The age of red blood cells in premature infants (ARIPI) randomized controlled trial: study design. Transfus Med Rev 2009, 23:55-61.
56. Friese R.S., Sperry J.L., Phelan H.A., Gentilello L.M. The use of leukoreduced red blood cell products is associated with fewer infectious complications in trauma patients. Am J Surg 2008, 196:56-61.
57. Phelan H.A., Eastman A.L., Aldy K., Carroll E.A., Nakonezny P.A., Jan T., et al. Prestorage leukoreduction abrogates the detrimental effect of aging on packed red cells transfused after trauma: a prospective cohort study. Am J Surg 2012, 203:198-204.
58. Romano G., Mastroianni C., Bancone C., Della Corte A., Galdieri N., Nappi G., et al. Leukoreduction program for red blood cell transfusions in coronary surgery: association with reduced acute kidney injury and in-hospital mortality. J Thorac Cardiovasc Surg 2010, 140:188-195.
59. Watkins T.R., Rubenfeld G.D., Martin T.R., Nester T.A., Caldwell E., Billgren J., et al. Effects of leukoreduced blood on acute lung injury after trauma: a randomized controlled trial. Crit Care Med 2008, 36:1493-1499.
60. Frietsch T., Karger R., Scholer M., Huber D., Bruckner T., Kretschmer V., et al. Leukodepletion of autologous whole blood has no impact on perioperative infection rate and length of hospital stay. Transfusion 2008, 48:2133-2142.